Is this email not displaying correctly?
View it in your browser.
Spring 2015
Dr. Nadeau

Dear Friend,

This week marks significant strides in allergy research! We invite you to catch up on groundbreaking developments published just this week in our Allergy Research Update. The Sean N. Parker Center for Allergy Research works across disciplines to attack the allergy epidemic—this issue highlights our partnership with Stanford's Pathology Department in a lively discussion with Pathology Department Chair Dr. Stephen Galli. In addition, you'll hear from teenage oral immunotherapy trial graduate and allergy writer Matthew. You'll also get a hopeful view into oral immunotherapy treatment in this CBS news video released yesterday featuring our Center.


Dr. Stephen Galli
Stanford School of Medicine's Pathology Department Chair, Dr. Stephen Galli had been lecturing for many years on allergy and asthma, but it wasn’t until he came across his nut-allergic colleague vomiting and subsequently collapsing in the hall of Stanford’s Pathology Department, that he had his first personal experience with anaphylaxis and the “magic,” as he puts it, of epinephrine. Read more.

"I am a graduate of a Phase One FDA approved food allergy study that was conducted at Stanford University under the watchful eye of Dr. Kari Nadeau. I started the study as a 14 year-old freshman in high school who was anaphylactic to wheat, rye, barley and oats.  Currently, I am a 16-year-old junior who eats a daily dose of wheat, rye, barley and oats." Read more.

Allergy Research Update

Recent Publications 
  • New study released today pinpoints region in human genome associated with peanut allergy in U.S. children. Read abstract.  
  • Learning Early About Peanut (LEAP) study finds that early introduction of peanuts may prevent development of peanut allergy. Read our Center's comments on the findings here.
  • A Stanford study published last month demonstrates that exposure to airborne polycyclic aromatic hydrocarbons is linked to epigenetic changes associated with allergy and asthma. Read abstract.
  • New study finds that low vitamin D may have a role in pediatric morbidity and mortality. Study concludes that measuring serum vitamin D levels postmortem may provide invaluable information on sudden unexplained death in children, in children dying from asthma, and in babies with fractures. 
  • A recent Australian study evaluates coadministration of probiotic with peanut oral immunotherapy. While sustained desensitization was achieved in 82% of children treated with probiotics and peanut OIT, Sean N. Parker Center for Allergy Research Director Dr. Kari Nadeau notes that with peanut OIT alone, a similar rate of success can be achieved in over 80% of peanut OIT patients. Further research is required to determine contributions of probiotics versus OIT. 
  • Mouse study shows that sensitization to a food allergen is increased in mice that have been treated with antibiotics. Additionally, the introduction of a Clostridia-containing microbiota protected mice against allergy sensitization. Thus far, these findings have not been replicated in people.
Current Research
  • Questionnaire-based study led by Sean N. Parker Center for Allergy Research at Stanford University finds that exposure to dogs in early life is associated with decreased incidence of food allergy. The study also found that ingestion of peanut in pregnancy was associated with increased incidence of food allergy in offspring. The study, conducted by validated questionnaire, surveyed 184 Stanford food allergy OIT patients and their mothers and had a control group of 171 participants. Stay tuned for more details on this study.

Upcoming Events

Packard Summer Scamper
The Lucile Packard Annual Summer Scamper is just a few months away! Mark your calendars for June 21, 2015. This event brings together a large outpouring of Center community members who run and walk together each year in support of allergy research. Details to come.


Clinical Trials

The Sean N. Parker Center for Allergy Research at Stanford University conducts many clinical trials with the goal of developing therapies for allergic disorders.

Our Center is currently enrolling volunteers aged 18-55 who are interested in participating in the NIH-funded Peanut Oral Immunotherapy: Safety, Efficacy, and Discovery (POISED) Study. If you are interested in being screened for this trial, please send us an email at

In the News

Encouraging News for Food Allergy Sufferers

ABC 7 
Stanford Allergy Program Changes Lives

City Visions: Can We Effectively Treat Deadly Food Allergies?

Mountain View Voice
A Nut a Day Keeps the Doctor Away

New York Times
Napster Co-Founder to Invest in Allergy Research

Napster Co-Founder Sean Parker Donates $24 Million to Stanford for Curing All Allergies in 10 Years

Sean Parker Gives $24 Million for Stanford Allergy Center

SF Gate
Sean Parker Donates $24 Million to Stanford Allergy Research

More news

Get Involved! 

Join our Community to receive our quarterly eNews, as well as invitations to events and talks led by members of our Center's medical team

Share this newsletter with friends and family affected by allergies.

Follow us on Facebook for up-to-the-minute updates on allergy research developments at Stanford.

Our Mission 

Transforming the lives of our patients and their families through innovative science and compassionate care.

Friend on Facebook Follow us on Facebook
(c) 2015 This newsletter is sent on behalf of the Sean N. Parker Center for Allergy Research at Stanford University. To opt out of future online communications from the Center, please follow the instructions in the footer of this email.